Table 2 Summary of clinically-relevant statistics of autoantibody-antigen reactivity combinations that are from 100 to 90% specific with ASD diagnosis in the training and validation set (combined data).
From: Risk assessment analysis for maternal autoantibody-related autism (MAR-ASD): a subtype of autism
Pattern | Training ASD + /subgroup | Validation ASD + /subgroup | ASD/subgroup | Precision | Precision drop | Total ASD % (n = 450) | Fisher’s exact test p value | OR (95% CI)a | OR p value |
|---|---|---|---|---|---|---|---|---|---|
CRMP1 + GDA | 15/15 | 4/4 | 19/19 | 1.00 | 0.00 | 4.2 | <0.0001 | 31.04 (1.8678–516.0620) | 0.0166 |
CRMP1 + CRMP2 | 12/12 | 4/4 | 16/16 | 1.00 | 0.00 | 3.6 | 0.0001 | 26.08 (1.5596–436.4170) | 0.0233 |
NSE + STIP1 | 8/8 | 6/6 | 14/14 | 1.00 | 0.00 | 3.1 | 0.0005 | 22.82 (1.3565–383.9379) | 0.0299 |
CRMP2 + STIP1 | 6/6 | 3/3 | 9/9 | 1.00 | 0.00 | 2 | 0.0064 | 14.78 (0.8573–254.8841) | 0.0637 |
LDHA + YBOX | 1/1 | 5/5 | 6/6 | 1.00 | 0.00 | 1.3 | 0.0393 | 10.04 (0.5640–178.9532) | 0.1164 |
LDHB + YBOX | 2/2 | 4/4 | 6/6 | 1.00 | 0.00 | 1.3 | 0.0393 | 10.04 (0.5640–178.9532) | 0.1164 |
GDA + YBOX | 5/5 | 1/1 | 6/6 | 1.00 | 0.00 | 1.3 | 0.0393 | 10.04 (0.5640–178.9532) | 0.1164 |
STIP1 + YBOX | 4/5 | 7/7 | 11/12 | 0.92 | 0.08 | 2.4 | 0.0161 | 8.56 (1.1010–66.7020) | 0.0402 |
CRMP1 + STIP1 | 15/17 | 3/3 | 18/20 | 0.90 | 0.10 | 4 | 0.0022 | 7.10 (1.6371–30.8292) | 0.0088 |